Clinical Characteristics of 162 Patients with Drug-Induced Liver And/or Kidney Injury

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2020 Feb 14

PMID 32051826

Citations 3

Authors

Xiaolin Wang

Xiangmei Chen

Affiliations

Soon will be listed here.

Abstract

Context: Drug-induced liver and kidney injuries are the most common adverse drug reactions in the clinic, and they have similar pathogeneses.

Aims: To analyze the clinical characteristics of patients with drug-induced liver and/or kidney injury.

Settings And Design: This was a retrospective study.

Methods And Materials: We analyzed data from 162 patients with drug-induced liver and/or kidney injury from 2008 to 2018 at the Chinese Rocket Force Characteristic Medical Center. Univariate and multivariate logistic analyses were performed on the drugs used, sex, age, weight, complications, and laboratory test results. Statistical analysis was performed using SPSS 25.0 statistical software.

Results: (1) The most common drugs causing organ injury in this study were antineoplastic drugs, antibiotics, traditional Chinese medicine, lipid-lowering drugs, and nonsteroidal anti-inflammatory drugs. (2) Among 22 patients with drug-induced liver and kidney injuries, 68.18% had a hepatocellular pattern, 13.64% had a mixed pattern, and 18.18% had a cholestatic pattern. Among the three groups, the value for creatinine was 0.002. (3) The value for urinary protein between the isolated kidney injury group and the liver and kidney injury group was 0.028. (4) Multivariate analysis showed that, among the drug-induced renal injury patients and all injury patients, those with a higher neutrophil percentage had a lower risk of liver injury (OR = 0.574, 95% CI: 0.390-0.846; OR = 0.545, 95% CI: 0.396-0.749).

Conclusions: (1) The serum creatinine level was higher in liver injury patients with the cholestatic pattern than in those with the hepatocellular or mixed pattern. (2) There was a significant difference in urinary protein between the isolated kidney and the liver and kidney injury groups. (3) Among patients with drug-induced organ injury, those with a higher neutrophils percentage had a lower risk of liver injury.

Citing Articles

Renal injury in NSAIDs: a real-world analysis based on the FAERS database.

Xu H, Cao J, Zhang H, Fei F, Tang D, Liu D Int Urol Nephrol. 2024; 57(3):957-963.

PMID: 39488798 DOI: 10.1007/s11255-024-04263-7.

Clinical Characteristics and Outcomes of Patients With Antithyroid Drug-Related Liver Injury.

Khan A, Ata F, Aziz A, Elamin H, Shahzad A, Yousaf Z J Endocr Soc. 2024; 8(1):bvad133.

PMID: 38178906 PMC: 10765380. DOI: 10.1210/jendso/bvad133.

Challenges in Pharmacovigilance: Variability in the Criteria for Determining Drug-Associated Acute Kidney Injury in Retrospective, Observational Studies.

Amatullah N, Stottlemyer B, Zerfas I, Stevens C, Ozrazgat-Baslanti T, Bihorac A Nephron. 2023; 147(12):725-732.

PMID: 37607496 PMC: 10776175. DOI: 10.1159/000531916.

References

Weber E, Lidberg K, Wang L, Bammler T, MacDonald J, Li M . Human kidney on a chip assessment of polymyxin antibiotic nephrotoxicity. JCI Insight. 2018; 3(24). PMC: 6338315. DOI: 10.1172/jci.insight.123673. View

Teschke R, Danan G . Molecular Research on Drug Induced Liver Injury. Int J Mol Sci. 2018; 19(1). PMC: 5796165. DOI: 10.3390/ijms19010216. View

Danan G, Benichou C . Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993; 46(11):1323-30. DOI: 10.1016/0895-4356(93)90101-6. View

Krones E, Wagner M, Eller K, Rosenkranz A, Trauner M, Fickert P . Bile acid-induced cholemic nephropathy. Dig Dis. 2015; 33(3):367-75. DOI: 10.1159/000371689. View

Fontana R, Watkins P, Bonkovsky H, Chalasani N, Davern T, Serrano J . Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009; 32(1):55-68. PMC: 3637941. DOI: 10.2165/00002018-200932010-00005. View

Wang S, Ding W . A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury. Gut. 2016; 66(4):565-566. PMC: 5460370. DOI: 10.1136/gutjnl-2016-312966. View

Radovanovic M, Dushenkovska T, Cvorovic I, Radovanovic N, Ramasamy V, Milosavljevic K . Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature. Am J Case Rep. 2018; 19:1152-1161. PMC: 6181557. DOI: 10.12659/AJCR.911393. View

Tujios S, Fontana R . Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol. 2011; 8(4):202-11. DOI: 10.1038/nrgastro.2011.22. View

Aithal G, Watkins P, Andrade R, Larrey D, Molokhia M, Takikawa H . Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011; 89(6):806-15. DOI: 10.1038/clpt.2011.58. View

10.

Izzedine H, Perazella M . Anticancer Drug-Induced Acute Kidney Injury. Kidney Int Rep. 2018; 2(4):504-514. PMC: 5720534. DOI: 10.1016/j.ekir.2017.02.008. View

11.

Amulic B, Cazalet C, Hayes G, Metzler K, Zychlinsky A . Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012; 30:459-89. DOI: 10.1146/annurev-immunol-020711-074942. View

12.

Nawaratne S, Brien J, Seeman E, Fabiny R, Zalcberg J, Cosolo W . Relationships among liver and kidney volumes, lean body mass and drug clearance. Br J Clin Pharmacol. 1998; 46(5):447-52. PMC: 1873697. DOI: 10.1046/j.1365-2125.1998.00812.x. View

13.

Aleo M, Luo Y, Swiss R, Bonin P, Potter D, Will Y . Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump. Hepatology. 2014; 60(3):1015-22. DOI: 10.1002/hep.27206. View

14.

Saijou E, Enomoto Y, Matsuda M, Kok C, Akira S, Tanaka M . Neutrophils alleviate fibrosis in the CCl-induced mouse chronic liver injury model. Hepatol Commun. 2018; 2(6):703-717. PMC: 5983199. DOI: 10.1002/hep4.1178. View

15.

Ju C, Reilly T . Role of immune reactions in drug-induced liver injury (DILI). Drug Metab Rev. 2012; 44(1):107-15. DOI: 10.3109/03602532.2011.645579. View

16.

Andrade R, Chalasani N, Bjornsson E, Suzuki A, Kullak-Ublick G, Watkins P . Drug-induced liver injury. Nat Rev Dis Primers. 2019; 5(1):58. DOI: 10.1038/s41572-019-0105-0. View

17.

Benichou C . Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol. 1990; 11(2):272-6. DOI: 10.1016/0168-8278(90)90124-a. View

18.

Fuchs T, Hewitt P . Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J. 2011; 13(4):615-31. PMC: 3231866. DOI: 10.1208/s12248-011-9301-x. View

19.

Hayashi P . Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States. Int J Mol Sci. 2016; 17(2):201. PMC: 4783935. DOI: 10.3390/ijms17020201. View

20.

Awdishu L, Mehta R . The 6R's of drug induced nephrotoxicity. BMC Nephrol. 2017; 18(1):124. PMC: 5379580. DOI: 10.1186/s12882-017-0536-3. View